These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 16328478)
1. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478 [TBL] [Abstract][Full Text] [Related]
2. [Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect]. He Q; Li X; Tao Y; Liu YZ; Yang LP; Ying SX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):483-7. PubMed ID: 15972147 [TBL] [Abstract][Full Text] [Related]
3. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes]. Wu LY; Li X; Chang CK; Ying SX; Pu Q Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. Irvine AE; Magill MK; Somerville LE; McMullin MF Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome. PĆ¼lhorn H; Herrmann M; Harms H; Jung A; Baumann I Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734 [TBL] [Abstract][Full Text] [Related]
7. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia. Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814 [TBL] [Abstract][Full Text] [Related]
8. Transformation of myelodysplastic syndromes into acute myeloid leukemias. Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365 [TBL] [Abstract][Full Text] [Related]
9. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes. Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408 [TBL] [Abstract][Full Text] [Related]
10. [The type I insulin-like growth factor receptor highly expressed in clonal cells of myelodysplastic syndromes]. He Q; Li X; Zhang Z; Zhang QX; Yang LP Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):744-7. PubMed ID: 22339909 [TBL] [Abstract][Full Text] [Related]
11. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes]. Zhang F; Hao Y; Pang W Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678 [TBL] [Abstract][Full Text] [Related]
12. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260 [TBL] [Abstract][Full Text] [Related]
13. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP]. Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085 [TBL] [Abstract][Full Text] [Related]
14. [Apoptotic characteristics of CD34 positive cells in myelodysplastic syndromes]. Li X; Pu Q; Liu YZ; Tao Y; Ying SX; Jiang QY; Shi J Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):355-7. PubMed ID: 12941189 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes. He Q; Li X; Zhang Z; Zhang Q; Xu F; Yang L; Tao Y; Liu Y Cancer Invest; 2010 Dec; 28(10):983-8. PubMed ID: 20569071 [TBL] [Abstract][Full Text] [Related]
16. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
17. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome. Wu L; Li X; Chang C; Ying S; He Q; Pu Q Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314 [TBL] [Abstract][Full Text] [Related]
18. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600 [TBL] [Abstract][Full Text] [Related]
19. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
20. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia. Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]